Glycosaminoglycans

tumor susceptibility 101 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34203832 Novel Tsg101 Binding Partners Regulate Viral L Domain Trafficking. 2021 Jun 15 1
2 29571744 The NC domain of HIV-1 Gag contributes to the interaction of Gag with TSG101. 2018 Jun 7
3 30068652 Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101. 2018 Oct 15 3
4 27280284 The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding. 2016 Jun 1
5 27648839 HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release. 2016 8
6 20929444 Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins. 2010 Dec 15 2
7 19053244 Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. 2008 Dec 19 2
8 19244744 [The action of TSG101 on HIV-1 budding and related inhibitors]. 2008 Dec 2
9 17428861 Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. 2007 Jun 1
10 15795524 Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infection. 2005 Mar 1
11 15126635 Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. 2004 May 1 4
12 15043208 HIV capsid assembly. 2003 Jan 1
13 11805336 Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. 2002 Jan 22 1
14 11595185 Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. 2001 Oct 5 1